Lakefront Biotherapeutics NV (AMS:LKFT)
Netherlands · Delayed Price · Currency is EUR 24.60
-0.44 (-1.76%)
Sep 4, 2026, 5:35 PM CET
AMS:LKFT Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, AMS:LKFT stock has a consensus rating of "Hold" and an average price target of €30.28. The average 1-year stock price forecast is 23.09% higher than the current stock price, while the lowest is €19.00 (-22.76%) and the highest is €44.80 (+82.11%).
Price Target: €30.28 (+23.09%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for AMS:LKFT stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 2 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 10 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains €22.00 | Sell | Maintains | €22.00 | -10.57% | Aug 11, 2026 |
| Kepler Capital | Kepler Capital | Sell Maintains €23.50 | Sell | Maintains | €23.50 | -4.47% | May 7, 2026 |
| UBS | UBS | Hold Maintains €30.00 | Hold | Maintains | €30.00 | +21.95% | Apr 1, 2026 |
| Bernstein | Bernstein | Hold Maintains €27.90 | Hold | Maintains | €27.90 | +13.41% | Mar 31, 2026 |
Financial Forecast
Revenue This Year
94.87M
from 1.11B
Decreased by -91.47%
Revenue Next Year
80.29M
from 94.87M
Decreased by -15.36%
EPS This Year
-4.25
from 10.21
EPS Next Year
-4.95
from -4.25
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.